In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
On 15 October, the Department of Health announced they have extended the shingles (herpes zoster) vaccine catch-up program available under the National Immunisation Program. The catch-up program offered to people aged 71-79 years was due to end on 31 October 2021, and has now been extended for a further 2 years to 31 October 2023. This program extension will allow those who missed or delayed vaccination due to pandemic restrictions or other reasons, extra time to get vaccinated with Zostavax® to protect against shingles disease.
Practices can automatically receive a monthly report of patients due and overdue for the Zostavax vaccine from Australian Immunisation Register (AIR). Email immunisation@cesphn.com.au for assistance with generating these recurring reports.
As Zostavax® is a live vaccine, it is contraindicated in some patients with immunocompromising conditions. It is important to review the latest guidance on herpes zoster in the Australian Immunisation Handbook and screen patients for contraindications using the screening tool in the Handbook.
Vaccination providers are also reminded that it is now mandatory to report all NIP vaccinations to the Australian Immunisation Register.
NCIRS has developed a new resource Administration of vaccines – Scope of practice for healthcare professionals provides an overview of the scope of practice relating to healthcare professionals prescribing and administering vaccines. This includes information for enrolled nurses, registered nurses, authorised nurse immunisers, and other health professionals.
The Australian Government’s new International COVID-19 Vaccination Certificate provides secure and internationally recognised proof of their COVID-19 vaccination history. The international certificate features a Quick Response (QR) code, which is generated using the COVID-19 vaccination information in the Australian Immunisation Register and your passport details. Access your international certificate using either your Medicare online account through myGov, the Express Plus Medicare mobile app, or contact AIR on 1800 653 809.
You can get your international certificate when you’re getting ready to travel if all the following apply:
you have a current Australian passport or foreign passport with an Australian visa
you’ve had at least one dose of an approved COVID-19 vaccine
your vaccination provider has reported your COVID-19 vaccinations to the Australian Immunisation Register (AIR)
The NSW Health factsheet on Release and recovery from COVID-19 has been updated and advises that there is no need to delay COVID-19 vaccination once a patient has recovered from their acute illness from SARS-CoV-2 infection. The document outlies the following key patient advice:
How soon should I get vaccinated?
People who have had COVID-19 can be vaccinated with a COVID-19 vaccine once they have recovered from their illness. There is no need to delay vaccination, however it may be deferred for up to 6 months. This is because a past infection reduces the chances of getting COVID-19 again for at least this amount of time.
How will I know when I can leave self-isolation?
You have received a text message (SMS) or email which confirms the end of your isolation period. This is called your medical clearance notice. This means that you are no longer infectious and cannot pass COVID-19 on to other people. Please keep the SMS or email of your medical clearance notice with you when you leave home in case you need it to show your employer or NSW Police.
COVID-19 testing after isolation
After you are released from isolation, routine COVID-19 testing (such as workplace testing) is not required for six months. This is because tests for COVID-19 may continue to give a positive result for a while after infection, even though you are no longer infectious.
If practices are unable to relocate excess doses locally (contacted PHN and local practices), email the Vaccine Operations Centre (VOC) covid19vaccineoperationscentre@health.gov.au for assistance. In some instances, the VOC may be able to arrange collection of excess doses for redistribution to another site. The VOC can only accept 20 vials or more of AstraZeneca; and 10 vials or more of Pfizer.
Proposed collection orders will be assessed for suitability, taking into consideration shelf life, time in transit, and clinic location. Practices will need to provide VOC with details about excess stock, including batch number, expiry date and number of excess doses, to be considered as part of this assessment. Once assessed, practices will receive a notification email confirming collection, or with disposal instructions.
If you have been unable to redirect your stock and the stock expires, please report the wastage through the COVID-19 Vaccine Administrative System (CVAS). Waste needs to be disposed of in accordance with the mandatory training, and vials must be disposed of in the provided sharps container to ensure they cannot be accessed.
AusVaxSafety has recently published their summary report which shows the percentage of reported adverse events, reported non-events, the percentage of those who saw a doctor or emergency department in the days after vaccination, and the most commonly reported events. The infographic also displays the vaccines given at each schedule point in 2020 and what diseases the vaccines protect against.
On 7 October 2021, enhancements were implemented to the Australian Immunisation Register (AIR) to remove the maximum dose number for the meningococcal B vaccine, Bexsero. Previously, the AIR only allowed a maximum of four doses to be reported for an individual. Vaccination providers can now report all Bexsero vaccines administered to an individual to the AIR, ensuring they have a complete immunisation record.
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments!
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…